SYCN and familial pancreatic carcinoma: Additionally, the Sycn protein is significantly increased in plasma from pancreatic cancer patients by enzyme-linked immunosorbent assay (ELISA) and integrated proteomic profiling of cell lines and pancreatic secretions [38].